Island Pharmaceuticals LtdASX: ILA

Quarterly Appendix 4C and Activities Report

· Issued by Island Pharmaceuticals Ltd via ASX

Filed with ASX ·

26 October 2026 ASX Announcement September 2026 Quarterly Activities Report • Government and regulatory approvals secured for the compassionate use of Galidesivir in patients infected in the Bundibugyo Ebola outbreak in Uganda • Real-world use of Galidesivir in Africa establishes an opportunity...

View Attachment

6ix is reading this filing.

Island Pharmaceuticals Ltd on 6ix

Earlier from Island Pharmaceuticals

All Island Pharmaceuticals news releases